Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 147 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]
3.Enlace a cita original Cita con resumen
Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN, for the Canadian Drug Safety Effectiveness Research Network (CDSERN). A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 2015;80:662-9. [Ref.ID 99608]
5.Enlace a cita original Cita con resumen
Gao Y, O'Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G, Sammon D, Molloy DW. Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 2013;3:22 de julio. [Ref.ID 95839]
6.Enlace a cita original Cita con resumen
Savarese G, Costanzo P, Cleland JGF, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure. J Am Coll Cardiol 2013;61:131-42. [Ref.ID 94624]
7. Cita con resumen
Anónimo. Candesartan, fetal malformations and use in pregnancy. Australian Prescriber 2012;35:98. [Ref.ID 92635]
9.Tiene citas relacionadas Cita con resumen
Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J, McCormack T, Forette F, Gil-Extremera B, Dumitrascu D, Staessen JA, Thijs L, Fletcher A, Bulpitt C, for the HYVET Study Group. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012;344:16. [Ref.ID 92218]
10.Tiene citas relacionadas Cita con resumen
Mancia G. Antihypertensives in octogenarians. BMJ 2012;344:8. [Ref.ID 92214]
11.
Arroll B, Doughty R, Andersen V. Investigation and management of congestive heart failure. BMJ 2010;341:190-5. [Ref.ID 88929]
12. Cita con resumen
Emery J, McKenzie A, Bulsara C, Holman D'Arcy. Next goal: consistency of packaging and labelling. BMJ 2010;341:64. [Ref.ID 88869]
13.Enlace a cita original
Bonet Monné S. Dades d'eficàcia dels IECA, ARA II i la combinació d'ambdós grups de fàrmacs. Butlletí d'Informació Terapèutica 2010;22:7-12. [Ref.ID 88270]
14. Cita con resumen
Hughes D, Ferner R. New drugs for old: disinvestment and NICE. BMJ 2010;340:690-2. [Ref.ID 88185]
15.Enlace a cita original
Montero Corominas D, García del Pozo J, de Abajo FJ. Utilización de antihipertensivos en España, 1992-2006. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2009:1-14. [Ref.ID 86455]
16. Cita con resumen
Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]
17. Cita con resumen
Suissa S. Calculation of number needed to treat. N Engl J Med 2009;361:424-5. [Ref.ID 86302]
18. Cita con resumen
Krum H, Abraham WT. Heart failure. Lancet 2009;373:941-55. [Ref.ID 85474]
19.Enlace a cita original
Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GYH, Patel A, on behalf of the ADVANCE Collaborative Group. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30:1128-35. [Ref.ID 85434]
Seleccionar todas
 
 1 a 20 de 147 siguiente >>